These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14501009)

  • 61. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunotherapy for Alzheimer's disease.
    Solomon B; Frenkel D
    Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.
    Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M
    Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials.
    Lavie V; Becker M; Cohen-Kupiec R; Yacoby I; Koppel R; Wedenig M; Hutter-Paier B; Solomon B
    J Mol Neurosci; 2004; 24(1):105-13. PubMed ID: 15314258
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice.
    Lee EB; Leng LZ; Zhang B; Kwong L; Trojanowski JQ; Abel T; Lee VM
    J Biol Chem; 2006 Feb; 281(7):4292-9. PubMed ID: 16361260
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
    Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice.
    Xiao S; Song LL; Li JT; Wang H; Yu N; Wang ZQ; Zhang Y; He JS; Hung T
    J Alzheimers Dis; 2020; 73(2):657-670. PubMed ID: 31839610
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model.
    Nojima J; Maeda A; Aoki S; Suo S; Yanagihara D; Watanabe Y; Yoshida T; Ishiura S
    Vaccine; 2011 Aug; 29(37):6252-8. PubMed ID: 21726591
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diversity of senile plaques in Alzheimer's disease as revealed by a new monoclonal antibody that recognizes an internal sequence of the Abeta peptide.
    Rábano A; Jiménez-Huete A; Acevedo B; Calero M; Ghiso J; Valdés I; Gavilondo J; Frangione B; Méndez E
    Curr Alzheimer Res; 2005 Oct; 2(4):409-17. PubMed ID: 16248846
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
    Moretto N; Bolchi A; Rivetti C; Imbimbo BP; Villetti G; Pietrini V; Polonelli L; Del Signore S; Smith KM; Ferrante RJ; Ottonello S
    J Biol Chem; 2007 Apr; 282(15):11436-45. PubMed ID: 17267402
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amyloid-beta immunisation for Alzheimer's disease.
    Wisniewski T; Konietzko U
    Lancet Neurol; 2008 Sep; 7(9):805-11. PubMed ID: 18667360
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Disaggregation of amyloid plaque in brain of Alzheimer's disease transgenic mice with daily subcutaneous administration of a tetravalent bispecific antibody that targets the transferrin receptor and the Abeta amyloid peptide.
    Sumbria RK; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Mol Pharm; 2013 Sep; 10(9):3507-13. PubMed ID: 23924247
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oligomeric Forms of Human Amyloid-Beta(1-42) Inhibit Antigen Presentation.
    Gericke C; Mallone A; Engelhardt B; Nitsch RM; Ferretti MT
    Front Immunol; 2020; 11():1029. PubMed ID: 32582162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.